Drug · DIN 02503441
PANCREASE MT 20
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since December 21, 2020; first marketed December 21, 2020.
- Drug Identification Number (DIN)
- 02503441
- Company (DIN owner)
- Vivus Llc.Campbell, California, United States
- Schedule
- Prescription; Schedule d
- Dosage form
- Capsule (Delayed-Release)
- Route
- Oral
- Therapeutic class (ATC)
- Multienzymes (lipase, protease etc) A09AA02
- Class
- Human
- Record last updated
- June 5, 2025
Active ingredients
As listed in the Drug Product Database.